252 related articles for article (PubMed ID: 6284362)
1. Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Gaynon PS; Baum ES; Krivit W; Hammond D
Cancer Treat Rep; 1982 Jul; 66(7):1583-4. PubMed ID: 6284362
[No Abstract] [Full Text] [Related]
2. [Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ueno K; Imajou K; Miyaoka K; Ozeki H
Gan To Kagaku Ryoho; 1987 Jan; 14(1):173-8. PubMed ID: 3541792
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Bleyer WA; Krivit W; Chard RL; Hammond D
Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
[TBL] [Abstract][Full Text] [Related]
4. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
Finklestein JZ; Higgins G; Krivit W; Hammond D
Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of intravenous allopurinol (NSC-1390) in pediatric neoplasia.
Donnenberg A; Holton CP; Mayer CM; Phillips LK
Cancer Chemother Rep; 1974; 58(5 Pt 1):737-9. PubMed ID: 4371949
[No Abstract] [Full Text] [Related]
9. Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.
Chard RL; Krivit W; Bleyer WA; Hammond D
Cancer Treat Rep; 1979; 63(11-12):1755-9. PubMed ID: 294306
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
11. Chemotherapy in childhood malignancies.
Koch K; Bloom GE; Wolfson SL
J Fla Med Assoc; 1971 Nov; 58(11):24-35. PubMed ID: 4330159
[No Abstract] [Full Text] [Related]
12. Phase II trial of prednimustine in glioblastoma multiforme.
Andersen J; Christensen L; Kongsholm H
Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
[TBL] [Abstract][Full Text] [Related]
13. [Early phase II trial of bestrabucil in hematological malignancies].
Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
Rosenstock JG; Donaldson MH
Cancer Treat Rep; 1976 Mar; 60(3):265-7. PubMed ID: 1063066
[No Abstract] [Full Text] [Related]
15. Phase I study of neocarzinostatin in children with cancer.
Rivera G; Howarth C; Aur RJ; Pratt CB
Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
[TBL] [Abstract][Full Text] [Related]
16. [Results of a clinical study of the preparation Lenvis in leukemias in children and adults].
Kondrat'eva NA; Kruglova GV; Kovaleva LG; Makhonova LA; Volkova MA
Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):16-21. PubMed ID: 7036140
[No Abstract] [Full Text] [Related]
17. [A phase II study of prednimustine in advanced ovarian cancer].
Grundsell H; Johnsson JE; Tropé C
Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
[No Abstract] [Full Text] [Related]
18. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
[TBL] [Abstract][Full Text] [Related]
20. Prednimustine in acute nonlymphocytic leukemia.
Ayulo MA; Preisler HD
Am J Clin Oncol; 1983 Apr; 6(2):207-9. PubMed ID: 6829495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
